𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Portfolio Theory and Cost-Effectiveness Analysis: A Further Discussion

✍ Scribed by Pedram Sendi; Maiwenn J. Al; Frans F. H. Rutten


Book ID
109078447
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
143 KB
Volume
7
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Productivity costs in cost-effectiveness
✍ Werner B.F. Brouwer; Marc A. Koopmanschap; Frans F.H. Rutten πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 25 KB

In this response we concentrate on what Weinstein et al. call the 'major disagreement' between the Erasmus group and the US Panel, which concerns the measurement of productivity losses during illness. We consider the consequences for the individual, for the employer and for the rest of society and a

Bayesian cost-effectiveness analysis wit
✍ Miguel A. NegrΓ­n; Francisco J. VΓ‘zquez-Polo πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 263 KB πŸ‘ 1 views

Cost-effectiveness analysis (CEA) compares the costs and outcomes of two or more technologies. However, there is no consensus about which measure of effectiveness should be used in each analysis. Clinical researchers have to select an appropriate outcome for their purpose, and this choice can have d

DISCOUNTING HEALTH AND COST-EFFECTIVENES
✍ James K. Hammitt πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 1 views

## SUMMARY Nord (2011) criticizes standard arguments which assert that consistency requires that future health benefits must be discounted at the same rate as future costs in cost‐effectiveness analysis (CEA). He suggests these arguments are misguided because they require transitivity of preference